Primary immunodeficiency diseases in a tuberculosis endemic region: challenges and opportunities. Glanzmann, B., Uren, C., de Villiers, N., van Coller, A., Glashoff, R. H., Urban, M., Hoal, E. G., Esser, M. M., Möller, M., & Kinnear, C. J. Genes and Immunity, September, 2018.
doi  abstract   bibtex   
While individual primary immunodeficiency diseases (PIDs) are rare, collectively they represent a significant burden of disease. Recent estimates show that about one million people in Africa suffer from a PID. However, data from African PID registries reflect only a small percentage of the estimated prevalence. This disparity is partly due to the lack of PID awareness and the masking of PIDs by the endemic pathogens. Over three million tuberculosis (TB) cases were reported in Africa in 2016, with many of these from southern Africa. Despite concerted efforts to address this high burden of disease, the underlying genetic correlates of susceptibility to TB remain poorly understood. High penetrance mutations in immune system genes can cause PIDs that selectively predispose individuals to TB and other mycobacterial diseases. Additionally, the identification of individuals at a heightened risk of developing TB or of presenting with severe or disseminated TB due to their genetic ancestry is crucial to promote a positive treatment outcome. The screening for and identification of PID mutations in TB-endemic regions by next-generation sequencing (NGS) represents a promising approach to improve the understanding of what constitutes an effective immune response to TB, as well as the range of associated PIDs and phenotypes.
@article{glanzmann_primary_2018,
	title = {Primary immunodeficiency diseases in a tuberculosis endemic region: challenges and opportunities},
	issn = {1476-5470},
	shorttitle = {Primary immunodeficiency diseases in a tuberculosis endemic region},
	doi = {10.1038/s41435-018-0041-0},
	abstract = {While individual primary immunodeficiency diseases (PIDs) are rare, collectively they represent a significant burden of disease. Recent estimates show that about one million people in Africa suffer from a PID. However, data from African PID registries reflect only a small percentage of the estimated prevalence. This disparity is partly due to the lack of PID awareness and the masking of PIDs by the endemic pathogens. Over three million tuberculosis (TB) cases were reported in Africa in 2016, with many of these from southern Africa. Despite concerted efforts to address this high burden of disease, the underlying genetic correlates of susceptibility to TB remain poorly understood. High penetrance mutations in immune system genes can cause PIDs that selectively predispose individuals to TB and other mycobacterial diseases. Additionally, the identification of individuals at a heightened risk of developing TB or of presenting with severe or disseminated TB due to their genetic ancestry is crucial to promote a positive treatment outcome. The screening for and identification of PID mutations in TB-endemic regions by next-generation sequencing (NGS) represents a promising approach to improve the understanding of what constitutes an effective immune response to TB, as well as the range of associated PIDs and phenotypes.},
	language = {eng},
	journal = {Genes and Immunity},
	author = {Glanzmann, Brigitte and Uren, Caitlin and de Villiers, Nikola and van Coller, Ansia and Glashoff, Richard H. and Urban, Michael and Hoal, Eileen G. and Esser, Monika M. and Möller, Marlo and Kinnear, Craig J.},
	month = sep,
	year = {2018},
	pmid = {30185814},
}

Downloads: 0